New Policy manager for the ABPI
pharmafile | November 13, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â ABPI, andrewÂ
The ABPI has appointed Andrew Hollingsworth as its new Policy manager who will take up the position on 25 November.
Hollingsworth will report directly to Audrey Yvernault who is the head of Policy and Public Affairs, and will be responsible for leading the ABPI’s work with patient groups including its Patient Organisation Forum. He will also lead on policy co-ordination and development.
Hollingsworth has a background in public affairs and policy in health and pharmaceuticals. He currently works as Public Affairs manager at Cancer Research UK, engaging with EU and Westminster policymakers on a variety of issues including medical research, clinical trials and tobacco control.
Previously he worked in the European Public Affairs team of Novartis in Brussels, where he was responsible for implementing advocacy on EU pharmaceuticals policy and legislation for the company’s Pharma and Consumer Health divisions. Prior to Novartis, he worked as a parliamentary assistant to a UK MEP, and previously held researcher positions at the London Assembly and House of Commons.
Hollingsworth said: “I am looking forward to joining the ABPI and making the case for the contribution of the industry to UK patients and the economy, including the benefits of fostering, and increasing access to, innovation. I am keen to develop the ABPI’s engagement with patient organisations in an open, transparent and constructive dialogue.”
Yvernault added: “I am delighted that Andrew is joining the public affairs team, completing the ABPI’s investment in its policy and advocacy capabilities. His appointment will complement the existing team and enable us to further our advocacy goals on behalf of members”.
Related Content
The November 2020 issue of Pharmafocus is available to read free online now!
The latest monthly edition of Pharmafocus is available to read for free online now!
UK life sciences industry does not want no-deal Brexit, says ABPI Chief
Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a …
ABPI Chief Executive Mike Thompson to retire by the end of 2019
The Association of the British Pharmaceutical Industry (ABPI) has announced that its Chief Executive Mike …
